Area of research
Physiology · Neurology
Research interest
Research interests include Progressive supranuclear palsy, Medicine, Biology, Genetics, Corticobasal degeneration, and Tauopathy.
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing
Copy Number Variation and Haplotype Analysis of <scp>17q21.31</scp> Reveals Increased Risk Associated with Progressive Supranuclear Palsy and Gene Expression Changes in Neuronal Cells
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology
Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies
Correction: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and <i>MAPT</i> Sub-haplotypes
A deep learning-based histopathology classifier for Focal Cortical Dysplasia
Whole-Genome Sequencing Analysis Reveals New Susceptibility Loci and Structural Variants Associated with Progressive Supranuclear Palsy
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
Tau deposition patterns are associated with functional connectivity in primary tauopathies
Long‐Duration Progressive Supranuclear Palsy: Clinical Course and Pathological Underpinnings
Binding characteristics of [ <sup>18</sup> F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
Distribution patterns of tau pathology in progressive supranuclear palsy
Assessment of <sup>18</sup>F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
Copathology in Progressive Supranuclear Palsy: Does It Matter?
Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy
DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases
Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy